UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

            

FORM 6-K


REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d-16 UNDER

THE  SECURITIES EXCHANGE ACT OF 1934


For the Month of   January 2013            


File No.   000-54598


Stellar Biotechnologies Inc.

(Name of Registrant)


332 E. Scott Street, Port Hueneme, CA 93041

 (Address of principal executive offices)


Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

FORM 20-F __X__

FORM 40-F  ______


Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ___



Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ___


SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized.


Stellar Biotechnologies Inc.

(Registrant)



Dated:  February 18, 2013

By:  /s/  "Darrell Brookstein"

Darrell Brookstein

Director


Exhibits:


99.1

Interim Financial Statements for the period ended November 30, 2012

99.2

Management Discussion and Analysis

99.3

Certification of CEO

99.4

Certification of CFO